1. Krowka MJ. Hepatopulmonary syndrome. Gut. 2000. 46:1–4.
2. Herve P, Lebrec D, Brenot F, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998. 11:1153–1166.
3. Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: distinction and dilemmas. Hepatology. 1997. 25:1282–1284.
4. Luo B, Liu L, Tang L, Zhang J, Ling Y, Fallon B. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats. Am J Physiol Gastrointest Liver Physiol. 2004. 286:G294–G303.
5. Zhang XJ, Katsuta Y, Akimoto T, Ohsuga M, Aramaki T, Takano T. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with common bile duct ligation. J Hepatol. 2003. 39:724–730.
6. Nunes H, Lebrec D, Mazmanian M, et al. Role of Nitric Oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med. 2001. 164:879–885.
7. Lee K-N, Jung W-J, Yoon SK, et al. Correlation of pulmonary vascular dilatation on HRCT to expression of eNOS in a rabbit model of hepatopulmonary syndrome. J Korean Radiol Soc. 2002. 44:475–483.
8. Abrams GA, Trauner M, Nathanson MH. Nitric oxide and liver disease. Gastroenterologist. 1995. 3:220–233.
9. Chabot F, Mestiri H, Sabry S, et al. Role of NO in the pulmonary hyporeactivity to phenylephrine in experimental biliary cirrhosis. Eur Respir J. 1996. 9:560–564.
10. Chang SW, O'Hara N. Pulmonary circulatory dysfunction in rats with biliary cirrhosis: an animal model of the hepatopulmonary syndrome. Am Rev Respir Dis. 1992. 145:798–805.
11. Fallon MB, Abrams GA, Luo B, et al. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology. 1997. 113:606–614.
12. Luo B, Abrams GA, Fallon MB. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol. 1998. 29:571–578.
13. Scott VL, Dodson SF, Kang Y. The hepatopulmonary syndrome. Surg Clin N Am. 1999. 79:23–41.
14. Fallon MB, Abrams GA, McGrath JW, et al. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol. 1997. 272:G779–G784.
15. McAdams HP, Erasmus J, Crockett R, Mitchell J, Godwin JD, McDermott VG. The hepatopulmonary syndrome; radiologic findings in 10 patients. AJR Am J Roentgenol. 1996. 166:1379–1385.
16. Lee KN, Lee HJ, Shin WW, Webb WR. Hypoxemia and liver cirrhosis (hepatopulmonary syndrome) in eight patients: comparison of the central and peripheral pulmonary vasculature. Radiology. 1999. 211:549–553.
17. Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology. 1997. 26:842–847.
18. Rolla G, Brussino L, Colagrande P. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med. 1998. 129:375–378.
19. Filep JG. Endothelial peptides: biological actions and pathophysiological significance in the lung. Life Sci. 1992. 52:119–133.
20. Rodriguez-Roisin R, Barbera JA. Hepatopulmonary syndrome: is NO the right answer? Gastroenterology. 1995. 113:682–684.
21. Oh KS, Bender TM, Bowen A, Ledesma-Medina J. Plain radiographic, nuclear medicine, and angiographic observations of hepatogenic pulmonary angiodysplasia. Pediatr Radiol. 1983. 13:111–115.
22. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome: clinical observations and lack of therapeutic response to somatostatin analogue. Chest. 1993. 104:515–521.
23. Krowka MJ. Clinical management of hepatopulmonary syndrome. Semin Liver Dis. 1993. 13:414–422.